106 related articles for article (PubMed ID: 19035297)
1. PGP9.5 methylation as a marker for metastatic colorectal cancer.
Mizukami H; Shirahata A; Goto T; Sakata M; Saito M; Ishibashi K; Kigawa G; Nemoto H; Sanada Y; Hibi K
Anticancer Res; 2008; 28(5A):2697-700. PubMed ID: 19035297
[TBL] [Abstract][Full Text] [Related]
2. PGP9.5 was less frequently methylated in advanced gastric carcinoma.
Mizukami H; Goto T; Kitamura Y; Sakata M; Saito M; Ishibashi K; Kigawa G; Nemoto H; Sanada Y; Hibi K
Hepatogastroenterology; 2009; 56(94-95):1576-9. PubMed ID: 19950834
[TBL] [Abstract][Full Text] [Related]
3. Hypomethylation of the protein gene product 9.5 promoter region in gallbladder cancer and its relationship with clinicopathological features.
Lee YM; Lee JY; Kim MJ; Bae HI; Park JY; Kim SG; Kim DS
Cancer Sci; 2006 Nov; 97(11):1205-10. PubMed ID: 16965602
[TBL] [Abstract][Full Text] [Related]
4. Aberrant methylation of the HACE1 gene is frequently detected in advanced colorectal cancer.
Hibi K; Sakata M; Sakuraba K; Shirahata A; Goto T; Mizukami H; Saito M; Ishibashi K; Kigawa G; Nemoto H; Sanada Y
Anticancer Res; 2008; 28(3A):1581-4. PubMed ID: 18630515
[TBL] [Abstract][Full Text] [Related]
5. Tumor suppressor function of PGP9.5 is associated with epigenetic regulation in prostate cancer--novel predictor of biochemical recurrence after radical surgery.
Mitsui Y; Shiina H; Hiraki M; Arichi N; Hiraoka T; Sumura M; Honda S; Yasumoto H; Igawa M
Cancer Epidemiol Biomarkers Prev; 2012 Mar; 21(3):487-96. PubMed ID: 22246902
[TBL] [Abstract][Full Text] [Related]
6. PGP9.5 as a marker for invasive colorectal cancer.
Yamazaki T; Hibi K; Takase T; Tezel E; Nakayama H; Kasai Y; Ito K; Akiyama S; Nagasaka T; Nakao A
Clin Cancer Res; 2002 Jan; 8(1):192-5. PubMed ID: 11801558
[TBL] [Abstract][Full Text] [Related]
7. Aberrant methylation of the UNC5C gene is frequently detected in advanced colorectal cancer.
Hibi K; Mizukami H; Shirahata A; Goto T; Sakata M; Saito M; Ishibashi K; Kigawa G; Nemoto H; Sanada Y
Anticancer Res; 2009 Jan; 29(1):271-3. PubMed ID: 19331160
[TBL] [Abstract][Full Text] [Related]
8. Methylation of TFPI2 gene is frequently detected in advanced well-differentiated colorectal cancer.
Hibi K; Goto T; Kitamura YH; Yokomizo K; Sakuraba K; Shirahata A; Mizukami H; Saito M; Ishibashi K; Kigawa G; Nemoto H; Sanada Y
Anticancer Res; 2010 Apr; 30(4):1205-7. PubMed ID: 20530429
[TBL] [Abstract][Full Text] [Related]
9. Aberrant methylation of the p16 gene is frequently detected in advanced colorectal cancer.
Goto T; Mizukami H; Shirahata A; Sakata M; Saito M; Ishibashi K; Kigawa G; Nemoto H; Sanada Y; Hibi K
Anticancer Res; 2009 Jan; 29(1):275-7. PubMed ID: 19331161
[TBL] [Abstract][Full Text] [Related]
10. Vimentin methylation as a marker for advanced colorectal carcinoma.
Shirahata A; Sakata M; Sakuraba K; Goto T; Mizukami H; Saito M; Ishibashi K; Kigawa G; Nemoto H; Sanada Y; Hibi K
Anticancer Res; 2009 Jan; 29(1):279-81. PubMed ID: 19331162
[TBL] [Abstract][Full Text] [Related]
11. p16 Methylation is frequently detected in the serum of metastatic colorectal cancer patients.
Hibi K; Mizukami H; Saito M; Kigawa G; Nemoto H
Hepatogastroenterology; 2014; 61(130):354-6. PubMed ID: 24901139
[TBL] [Abstract][Full Text] [Related]
12. Association of promoter methylation of VGF and PGP9.5 with ovarian cancer progression.
Brait M; Maldonado L; Noordhuis MG; Begum S; Loyo M; Poeta ML; Barbosa A; Fazio VM; Angioli R; Rabitti C; Marchionni L; de Graeff P; van der Zee AG; Wisman GB; Sidransky D; Hoque MO
PLoS One; 2013; 8(9):e70878. PubMed ID: 24086249
[TBL] [Abstract][Full Text] [Related]
13. Identification of methylation-silenced genes in colorectal cancer cell lines: genomic screening using oligonucleotide arrays.
Fukutomi S; Seki N; Koda K; Miyazaki M
Scand J Gastroenterol; 2007 Dec; 42(12):1486-94. PubMed ID: 17994469
[TBL] [Abstract][Full Text] [Related]
14. Methylation of HACE1 in gastric carcinoma.
Sakata M; Kitamura YH; Sakuraba K; Goto T; Mizukami H; Saito M; Ishibashi K; Kigawa G; Nemoto H; Sanada Y; Hibi K
Anticancer Res; 2009 Jun; 29(6):2231-3. PubMed ID: 19528486
[TBL] [Abstract][Full Text] [Related]
15. Detection of TFPI2 methylation in the serum of colorectal cancer patients.
Hibi K; Goto T; Shirahata A; Saito M; Kigawa G; Nemoto H; Sanada Y
Cancer Lett; 2011 Dec; 311(1):96-100. PubMed ID: 21820798
[TBL] [Abstract][Full Text] [Related]
16. Methylation of the DFNA5 gene is frequently detected in colorectal cancer.
Yokomizo K; Harada Y; Kijima K; Shinmura K; Sakata M; Sakuraba K; Kitamura Y; Shirahata A; Goto T; Mizukami H; Saito M; Kigawa G; Nemoto H; Hibi K
Anticancer Res; 2012 Apr; 32(4):1319-22. PubMed ID: 22493364
[TBL] [Abstract][Full Text] [Related]
17. Methylation of the homeobox gene, HOPX, is frequently detected in poorly differentiated colorectal cancer.
Harada Y; Kijima K; Shinmura K; Sakata M; Sakuraba K; Yokomizo K; Kitamura Y; Shirahata A; Goto T; Mizukami H; Saito M; Kigawa G; Nemoto H; Hibi K
Anticancer Res; 2011 Sep; 31(9):2889-92. PubMed ID: 21868534
[TBL] [Abstract][Full Text] [Related]
18. WNT5A gene is aberrantly methylated from the early stages of colorectal cancers.
Hibi K; Mizukami H; Goto T; Kitamura Y; Sakata M; Saito M; Ishibashi K; Kigawa G; Nemoto H; Sanada Y
Hepatogastroenterology; 2009; 56(93):1007-9. PubMed ID: 19760930
[TBL] [Abstract][Full Text] [Related]
19. MGMT gene is aberrantly methylated from the early stages of colorectal cancers.
Hibi K; Goto T; Mizukami H; Kitamura Y; Sakata M; Saito M; Ishibashi K; Kigawa G; Nemoto H; Sanada Y
Hepatogastroenterology; 2009; 56(96):1642-4. PubMed ID: 20214209
[TBL] [Abstract][Full Text] [Related]
20. Silencing of the UCHL1 gene in human colorectal and ovarian cancers.
Okochi-Takada E; Nakazawa K; Wakabayashi M; Mori A; Ichimura S; Yasugi T; Ushijima T
Int J Cancer; 2006 Sep; 119(6):1338-44. PubMed ID: 16642472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
